Ligand validation:6Q5F

CTJ: 1-({(2R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino}-2-oxoethyl]-4-carboxy-3,6-dihydro-2H-1,3-thiazin-5-yl}methyl)pyridinium

CTJ is a Ligand Of Interest in 6Q5F designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6Q5F_CTJ_C_301	41%	3%	0.189	0.905	4.29	2.13	11	6	5	0	100%	0.9862
6Q5F_CTJ_A_301	34%	2%	0.185	0.867	4.2	2.5	14	10	2	0	100%	0.9776
8PEC_CTJ_A_301	44%	2%	0.203	0.93	4.5	2.25	14	6	7	0	100%	0.6262
3OCN_CTJ_A_1	58%	7%	0.135	0.943	2.02	2.86	5	7	1	0	84%	0.8378
4X55_CTJ_B_301	50%	13%	0.14	0.889	1.66	2.32	2	7	1	0	100%	0.9676

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.